Which statement correctly describes the Duo-Nebulizer's delivery?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the NREMT Advanced-EMT Test. Use flashcards and multiple choice questions, complete with hints and explanations. Ready yourself for success on your exam!

Multiple Choice

Which statement correctly describes the Duo-Nebulizer's delivery?

Explanation:
The Duo-Nebulizer provides a combination bronchodilator therapy: a short-acting beta-2 agonist together with ipratropium bromide. The beta-2 agonist relaxes the airway smooth muscle by stimulating beta-2 receptors, producing rapid bronchodilation. Ipratropium bromide is an anticholinergic that blocks muscarinic receptors, reducing acetylcholine-driven bronchoconstriction. Using both agents together yields greater and more sustained airway opening than either agent alone. Antibiotics are not bronchodilators and aren’t part of this delivery. So this device delivers both a beta-2 agonist and ipratropium bromide.

The Duo-Nebulizer provides a combination bronchodilator therapy: a short-acting beta-2 agonist together with ipratropium bromide. The beta-2 agonist relaxes the airway smooth muscle by stimulating beta-2 receptors, producing rapid bronchodilation. Ipratropium bromide is an anticholinergic that blocks muscarinic receptors, reducing acetylcholine-driven bronchoconstriction. Using both agents together yields greater and more sustained airway opening than either agent alone. Antibiotics are not bronchodilators and aren’t part of this delivery. So this device delivers both a beta-2 agonist and ipratropium bromide.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy